2 results
Approved WMOCompleted
The objective is to study the effect of beta-agonist and beta-antagonist treatment on human bone remodeling.
Approved WMOSuspended
To compare event-free survival (EFS) of the experimental treatment arm including ATO/ATRA and idarubicin with standard treatment based on ATRA plus chemotherapy (AIDA regimen).